[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.17.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 2, 1995

Update: Management of Patients With Suspected Viral Hemorrhagic Fever—United States

JAMA. 1995;274(5):374-375. doi:10.1001/jama.1995.03530050020009
Abstract

MMWR. 1995;44:475-479

IN 1988, CDC published guidelines for managing patients with suspected viral hemorrhagic fever (VHF).1 Pending a comprehensive review of the 1988 guidelines, this notice provides interim recommendations that update the 1988 guidelines for health-care settings in the United States. This update applies to four viruses that cause syndromes of VHF: Lassa, Marburg, Ebola, and Congo-Crimean hemorrhagic fever viruses; although the risk and/or mode of nosocomial transmission differs for each of these viruses, the limited data do not permit clear distinctions.

Background  In Africa, transmission of VHF has been associated with reuse of unsterile needles and syringes and with provision of patient care without appropriate barrier precautions to prevent exposure to virus-containing blood and other body fluids (including vomitus, urine, and stool). The risks associated with various body fluids have not been well defined as most caregivers who acquired infection had multiple contacts with multiple fluids. Epidemiologic studies

First Page Preview View Large
First page PDF preview
First page PDF preview
×